Company registration number 06533761 (England and Wales)
MEDICOS PRIME HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MEDICOS PRIME HEALTH LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDICOS PRIME HEALTH LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
2,113,488
2,286,159
Tangible assets
4
32,046
16,230
Investment property
5
660,469
660,469
2,806,003
2,962,858
Current assets
Stocks
121,936
125,958
Debtors
6
393,089
377,318
Cash at bank and in hand
1,094,693
823,184
1,609,718
1,326,460
Creditors: amounts falling due within one year
7
(1,916,745)
(1,930,711)
Net current liabilities
(307,027)
(604,251)
Total assets less current liabilities
2,498,976
2,358,607
Creditors: amounts falling due after more than one year
8
(84,654)
(367,031)
Provisions for liabilities
(8,219)
(8,219)
Net assets
2,406,103
1,983,357
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
2,406,003
1,983,257
Total equity
2,406,103
1,983,357
MEDICOS PRIME HEALTH LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 16 September 2025 and are signed on its behalf by:
Mr Manoj Patel
Mr Jay Manoj Patel
Director
Director
Company registration number 06533761 (England and Wales)
MEDICOS PRIME HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Medicos Prime Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is Suite 3, Congress House, 14 Lyon Road, Harrow, Middlesex, England, HA1 2EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
20% Straight line on cost
Motor vehicles
25% Straight line on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Investment properties

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

MEDICOS PRIME HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

MEDICOS PRIME HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
27
28
MEDICOS PRIME HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
3,453,425
Amortisation and impairment
At 1 April 2024
1,167,266
Amortisation charged for the year
172,671
At 31 March 2025
1,339,937
Carrying amount
At 31 March 2025
2,113,488
At 31 March 2024
2,286,159
4
Tangible fixed assets
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
Cost
At 1 April 2024
173,187
9,000
182,187
Additions
30,552
-
0
30,552
At 31 March 2025
203,739
9,000
212,739
Depreciation and impairment
At 1 April 2024
156,958
8,999
165,957
Depreciation charged in the year
14,736
-
0
14,736
At 31 March 2025
171,694
8,999
180,693
Carrying amount
At 31 March 2025
32,045
1
32,046
At 31 March 2024
16,229
1
16,230
5
Investment property
2025
£
Fair value
At 1 April 2024 and 31 March 2025
660,469

Investment property comprises of a property from where one branch's business is conducted. The fair value of the investment property has been arrived at by the directors, on the basis of an open market value basis by reference to market evidence of transaction prices for similar properties.

MEDICOS PRIME HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
291,177
283,504
Other debtors
101,912
93,814
393,089
377,318
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
39,012
39,012
Trade creditors
447,444
436,283
Amounts owed to group undertakings and undertakings in which the company has a participating interest
1,349,681
1,340,443
Taxation and social security
63,055
108,911
Other creditors
17,553
6,062
1,916,745
1,930,711
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
84,654
367,031
9
Parent company

The ultimate controlling party is Jay Holdings Limited who owns 100% share capital of the company.

2025-03-312024-04-01falsefalsefalse17 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr Manoj PatelMr Jay Manoj Patel065337612024-04-012025-03-31065337612025-03-31065337612024-03-3106533761core:NetGoodwill2025-03-3106533761core:NetGoodwill2024-03-3106533761core:FurnitureFittings2025-03-3106533761core:MotorVehicles2025-03-3106533761core:FurnitureFittings2024-03-3106533761core:MotorVehicles2024-03-3106533761core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3106533761core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3106533761core:ShareCapital2025-03-3106533761core:ShareCapital2024-03-3106533761core:RetainedEarningsAccumulatedLosses2025-03-3106533761core:RetainedEarningsAccumulatedLosses2024-03-3106533761bus:Director12024-04-012025-03-3106533761bus:Director22024-04-012025-03-3106533761core:Goodwill2024-04-012025-03-3106533761core:FurnitureFittings2024-04-012025-03-3106533761core:MotorVehicles2024-04-012025-03-31065337612023-04-012024-03-3106533761core:NetGoodwill2024-03-3106533761core:NetGoodwill2024-04-012025-03-3106533761core:FurnitureFittings2024-03-3106533761core:MotorVehicles2024-03-31065337612024-03-3106533761core:CurrentFinancialInstruments2025-03-3106533761core:CurrentFinancialInstruments2024-03-3106533761core:WithinOneYear2025-03-3106533761core:WithinOneYear2024-03-3106533761core:Non-currentFinancialInstruments2025-03-3106533761core:Non-currentFinancialInstruments2024-03-3106533761bus:PrivateLimitedCompanyLtd2024-04-012025-03-3106533761bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106533761bus:FRS1022024-04-012025-03-3106533761bus:AuditExemptWithAccountantsReport2024-04-012025-03-3106533761bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP